ODAIA has launched Marketing Intelligence, an AI solution that helps pharmaceutical companies orchestrate personalised campaigns to healthcare professionals. The system analyses prescribing data, engagement signals, CRM records and physician attributes in real time to deliver tailored messaging, channels and timing to individual doctors. The solution addresses an industry problem where 40–70% of pharma's tens of billions spent annually on HCP engagement fails to deliver meaningful impact due to misaligned targeting and timing. Marketing Intelligence scores each HCP individually rather than using static segmentation, creating customised campaign sequences at the national provider identifier level. In one deployment, the system evaluated 70,000 HCPs and achieved an 80% engagement rate with 39.7% conversion to prescription. Four of the top 15 global pharmaceutical companies now use ODAIA's technology.

ODAIA Marketing Intelligence brings real-time, individualized campaign orchestration to pharma HCP engagement. ODAIA Marketing Intelligence is now generally available - bringing individualized HCP campaign sequencing, automated execution, and real Rx attribution to pharma commercial teams. Published on May 12, 2026 Proven AI solution for top pharma companies analyzes hundreds of thousands of signals to recommend the best campaign sequences mapped to every HCP's prescribing journey. BOSTON - May 12, 2026. ODAIA today introduced Marketing Intelligence, an AI solution that helps pharma marketing and brand teams orchestrate personalized campaigns to healthcare professionals (HCPs). Now available, Marketing Intelligence analyzes prescribing data, engagement signals, CRM records, and physician attributes in real time to deliver the best message, channel, content, and timing at the right moment in every HCP's decision-making journey. As new behavioral signals emerge, the solution continuously refines engagement strategies and tailors campaign sequences to each physician's needs. "Pharma marketers invest heavily in omnichannel, but are forced to settle for backwards-looking data, static segmentation and targeting, and campaign execution that can't adapt to how HCPs actually behave. Marketing Intelligence evaluates every physician individually, pinpoints where they are in their prescribing journey, and orchestrates face-to-face and digital touchpoints - with attribution tied directly to prescription lift." - Jacqueline Markle, VP Pharma Technical Strategy, ODAIA Intelligence Jacqueline Markle is a 20-year industry veteran in pharma commercial data science and analytics, with prior roles at AstraZeneca and Sage Therapeutics. Most brand teams still rely on consultants to build clusters of physician personas and rules-based channel sequences informed by data that is months old. Target lists get handed to agencies, each vendor matches its own subset, and the same HCP receives redundant messages across channels, often long after a clinical decision has been made. Recent industry analyses suggest pharma spends tens of billions of dollars globally on HCP engagement each year, with 40-70% failing to deliver meaningful impact because of misaligned targeting, channel, and timing, indicating a multi-billion-dollar annual waste problem in the US alone. What Marketing Intelligence does. Marketing Intelligence closes the gap between pharma commercial strategy and execution in four ways: * Convert objectives into execution - drive targeting, sequencing, engagement, and budget decisions by translating brand strategy decks and strategic pillars into weighted objectives * Score every HCP - instead of grouping HCPs by clusters or personas, evaluate each one against your objectives using real-time engagement, prescribing, and patient signals * Sequence personalized journeys - orchestrate the best sequence of message, channels, and timing for each HCP across digital and face-to-face by mapping engagement and approved content to each journey stage * Control spend and channels - set and adjust budget allocations to match your flighting calendar by brand, objective, channel, or vendor to match campaign priorities as market conditions shift and new HCP behavioral signals emerge Marketing Intelligence seamlessly connects to existing marketing platforms to trigger real-time recommendations, while automatically pulling-in new engagement and prescription data daily or weekly. This creates a constant feedback loop that replaces slow, quarterly refresh cycles that are typical in traditional pharma marketing analytics. Results in practice. In one recent pharma commercial deployment, Marketing Intelligence evaluated 70,000 HCPs, concentrating marketing spend on the physicians most likely to respond. The solution delivered an 80% engagement rate and a 39.7% conversion to prescription following engagement, while also surfacing active prescribers that the customer's existing process had missed. Explore the full case study. "Customers repeatedly tell us that they didn't know there was a solution out there that could work this way. Pharma commercial teams are used to waiting months for a marketing mix model analysis. With AI, we can do it every week, down to the individual national provider identifier (NPI) level for each HCP, tied to actual prescribing outcomes. Marketing Intelligence is proven, in production, and delivering measurable business results in pharma today." - Jacqueline Markle, VP Pharma Technical Strategy, ODAIA Intelligence Marketing Intelligence is available now. Your field and digital teams, finally working from the same insights. See what it could look like for your brand. See ODAIA in action. Experience how ODAIA can transform your commercial pharma srategy.